Letter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC?
dc.contributor.author | Sanoff, Hanna K. | |
dc.contributor.author | Chang, YunKyung | |
dc.contributor.author | Lund, Jennifer L. | |
dc.contributor.author | O'Neil, Bert H. | |
dc.contributor.author | Dusetzina, Stacie B. | |
dc.contributor.department | Department of Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2017-08-02T13:56:43Z | |
dc.date.available | 2017-08-02T13:56:43Z | |
dc.date.issued | 2017-08 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Sanoff, H. K., Chang, Y., Lund, J. L., O'Neil, B. H. and Dusetzina, S. B. (2017), Letter to the Editor: Immortal Time Bias or Sorafenib Effect in Elderly Patients with HCC?. Hepatology, 66 (2), 678-679. http://dx.doi.org/10.1002/hep.29250 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/13696 | |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.isversionof | 10.1002/hep.29250 | en_US |
dc.relation.journal | Hepatology | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | sorafenib | en_US |
dc.subject | hepatocellular carcinoma | en_US |
dc.subject | immortal time bias | en_US |
dc.title | Letter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC? | en_US |
dc.type | Article | en_US |